TipRanks
Go Ultimate55% OFF

Mathieu Burtnyk Insider Profile

4 Followers

Mathieu Burtnyk, Chief Technology Officer at Profound Medical, holds 58.21K shares in Profound Medical (Ticker: TSE:PRN).

Mathieu Burtnyk's Trading History

PRN
Profound Medical
Sep 16, 2026Chief Technology OfficerUninformative Sell―C$534.39K
TSE:PRN
Insider Shares: 58.21K (15.93%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 16, 2026Uninformative SellC$0.002,970C$0.00――
Jun 25, 2026Uninformative SellC$0.0011,693C$0.00――
Nov 22, 2025Uninformative SellC$0.001,486C$0.00――
Sep 16, 2025Uninformative SellC$17.16K3,048C$5.63――
Aug 26, 2025Uninformative SellC$40.31K6,763C$5.96――

You May Also Like

Mathieu Burtnyk insider profile FAQ

What is the percentage of profitable transactions made by Mathieu Burtnyk?
The percentage of profitable transactions made by Mathieu Burtnyk is 0%.
What is the average return per transaction made by Mathieu Burtnyk?
The average return per transaction made by Mathieu Burtnyk is -16.70%.
What stocks does Mathieu Burtnyk hold?
Mathieu Burtnyk holds: TSE:PRN stocks.
What was Mathieu Burtnyk's most profitable transaction?
Mathieu Burtnyk’s most profitable transaction was an Informative Buy of TSE:PRN stock on December 23, 2023. The return on the trade was -16.70%.
What is Mathieu Burtnyk's role in Profound Medical?
Mathieu Burtnyk's role in Profound Medical is Chief Technology Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.